Make Sure that You File Your Avandia Claims Lawsuit on Time

Posted by on Oct 15, 2013 in Lawsuits, Pharmaceutical Drugs, Product Liability | 2 comments

The introduction of the oral drug Avandia or Rosiglitazone was welcomed by doctors as it served as a great alternative to patients who, for medical reasons, could not take Actos or any other drugs for Type II diabetes. Rosiglitazone was either manufactured alone or was combined with other drugs to form a new medication; such is the case with Avandamet (Rosiglitazone combined with metformin) and Avandaryl (combination of Rosiglitazone and glimepiride).

Avandia can be prescribed alone or with another diabetes medicine and is usually taken with proper diet and exercise. It is, however, not intended for type 1 diabetics due to their system’s inability to produce enough insulin or total failure to produce insulin.

Avandia was manufactured by the UK pharmaceutical company SmithKlineBeecham Corporation and approved for distribution by the US Food and Drug Administration in May 1999. SmithKlineBeecham Corporation is now registered under the name GlaxoSmithKline after its merger with another UK firm, Glaxo Wellcome, in January 2000. The merger resulted to the formation of world’s largest drug company.

After becoming Glaxo’s second most-bought product and after being prescribed to more than six million patients worldwide, Avandia’s sale dropped following a public warning by the FDA which said that the drug increased the possibility of congestive heart failure and fatal heart attack in patients. It was even issued a block box warning, FDA’s most serious warning on a drug due to its life-threatening effects.

Different studies made on the drug, however, showed conflicting results; this means that while many did suffer from heart ailments, some others did not. Thus, despite the black box warning, the FDA decided not to recall the drug; it required further studies about Avandia, however.

The many cases of heart ailments and deaths where Avandia is named to be the cause, plus Glaxo’s failure to include on the drug’s label its risks to health are enough to render the firm negligent of its responsibilities towards millions of patients. This means patients can run after Glaxo for compensation. But, patients ought to know that there is a statutory deadline for filing claims; missing this deadline will outrighlty disqualify them from making any claims.

The National Injury Law Center has been, and continues to be, a dedicated defender of patients’ rights. It has a website where patients’ questions about drugs’ adverse effects and medical errors are clearly answered and patients’ legal options are provided. Know if you are qualified to file a lawsuit claim, but make sure you file it on time, otherwise, you lose this right totally.

Read More

Popular Bitcoin Exchange Topic of Breach of Contract Lawsuit

Posted by on Oct 11, 2013 in Lawsuits | 2 comments

Popular Bitcoin Exchange Topic of Breach of Contract Lawsuit

The world’s top Bitcoin exchange, Mt. Gox, is facing a breach of contract lawsuit after allegedly failing to meet the contractual obligations of the partnership it signed with CoinLab. The partnership was designed to simplify Japan-based Mt. Gox’s business with Bitcoin traders in the United States and Canada in light of proposed regulations.

Bitcoins are a virtual currency generated by a complex hashing algorithm. A Bitcoin is generated when a computer solves the algorithm. The complexity of the hashing algorithm increases with every Bitcoin that is generated, meaning the next one will take longer to be discovered. The process of generating Bitcoins is called “mining” and people build powerful computers for the sole purpose of mining the anonymous currency. Over the past few months, the price of Bitcoins has fluctuated dramatically, reaching a high of $266 per Bitcoin in April, and then dropping to their current (as of writing) value of $90 apiece. Presently more than $23 million worth of Bitcoins have been mined around the world.

Mt. Gox is a business that exchanges Bitcoins for physical currency. Since Bitcoins are not yet a widely accepted form of payment, the service enables Bitcoin owners to increase the liquidity of their investment in the virtual cash. Mt. Gox entered a deal with CoinLab in February, allowing the smaller company to handle all of its U.S. and Canada transactions. However, CoinLab claims that Mt. Gox failed to share crucial information and server access it needed to carry on its duties as a Bitcoin exchange, resulting in a breach of contract.

In all, CoinLab claims Mt. Gox breached its contract in at least eight different ways. The lawsuit seeks $75 million in damages and is sure to keep business lawyers on both sides of it busy for months to come. Hopefully they can settle their dispute soon, and in a way that does not harm the people who have put their faith in both of these companies.

Read More

Texas Law Firm Facing Gender Discrimination Lawsuit

Posted by on Apr 10, 2013 in Discrimination, Lawsuits | 1 comment

A female partner at a Dallas-based law firm has filed a gender discrimination suit against the firm.

She alleges that the firm has upheld a policy that prohibited employee pairs of opposite genders from working together or fraternizing outside of the office. Because of the fact that the people in power at the firm are all men, she is making a case that the policy, which has since been repealed, hindered the growth of her career. The woman says the firm has been aware of her issues with these policies for as long as half a year, but claims her protests were met with resentment.

The firm believes that it decisions and actions will all hold up in a court of law and that the plaintiff of the suit has no evidence to back up her claims.

The firm probably put the offending rule in effect to prevent sexual harassment, but has instead created a discrimination problem. If it had treated its employees as responsible adults who are capable of behaving professionally, chances are it would not have to deal with an internal lawsuit.

Read More

Lawsuit Accuses Anheuser-Busch InBev of Watering Down Beers

Posted by on Mar 5, 2013 in Lawsuits | 0 comments

Lawsuit Accuses Anheuser-Busch InBev of Watering Down Beers

While it may not come as a surprise to beer enthusiasts, a class action lawsuit filed against the world’s largest and most profitable alcoholic beverage company, Anheuser-Busch InBev, is accusing the brewer of adding water to its beer before sealing cans and bottles.

The accusation is being made against 10 of the company’s products, including Budweiser, Bud Ice, Michelob Ultra, and Bud Light Lime. The class action suit has been filed in seven states and alleges that the company is cheating consumers by not including the advertised alcohol by volume in their products. The Alcohol and Tobacco Tax and Trade Bureau regulates claims made on alcohol labeling.

The lawyer representing the class claims that several higher-ups from the company’s 13 U.S. breweries supplied him with the information that is the basis for the suit. According to the lawsuit, the watered down beer loses between three and eight percent of its alcohol content. Anheuser-Busch InBev denies the allegations against it, claiming it sells the highest quality beer it can. Nonetheless, the attorney is confident that the evidence he has will prove his claims. The lawsuits each seek damages $5 million.

In 2011, the company produced more than three billion gallons of malt beverages worldwide and made $22 billion in profits.

Read More